INFI Infinity Pharmaceuticals Inc.

$2.2 +0.46%

368,098 Shares Traded
837,123 Average Volume (last 30 days)

as of April 19, 2018 EST IEX Real-Time Price

Free Newsletter Sign Up

Short Pain Metrics

Approximate Amount of Money Shorts Have Lost on the Day: $28.15 thousand
If Intiated on the First, Shorts Have Realized a Year to Date Return of:1.35%
If Intiated One Month Ago, Shorts Have Realized a Return of:12.35%
If Initiated Five Days ago, Shorts Have Realized a Return of:2.22%
Peer Potential Short Squeezes Near Real Time Screener
*Please note the actual returns of shorts could be different as they started from different points.

Daily Indicators

Daily Short Pain Indicator [i] - Always Use Fundamentals on EverythingNeutral
200 Day Moving Average Indicator Bullish
50 Day Moving Average Indicator Bullish
52 Week High/Low Indicator Neutral

Short Stats

Short Percent to Float 5.72%
Short Interest2.81 million
Float49.18 million
Short Ratio2.68
Market Cap$114.32 million
Market Maker ActivityDaily Short Volume

News

04-12-2018
Daily Insider Ratings Round Up 4/11/18: INFI, ETM, LGCY, CCUR, OPK, DEX (SeekingAlpha)
03-27-2018
Infinity Pharmaceuticals (INFI) Presents At BioCentury's 25th Annual Future Leaders In The Biotech Industry Conference - Slideshow (SeekingAlpha)
03-26-2018
Infinity to Present at Two Upcoming Conferences (PR Newswire)
03-21-2018
Infinity To Present At BioCentury's 25th Annual Future Leaders In The Biotech Industry Conference (PR Newswire)
03-15-2018
Infinity Pharmaceuticals' (INFI) CEO Adelene Perkins on Q4 2017 Results - Earnings Call Transcript (SeekingAlpha)
03-15-2018
Infinity Pharmaceuticals beats by $0.11 (SeekingAlpha)
03-15-2018
Infinity Pharmaceuticals Provides Company Update and Reports Fourth Quarter and Full Year 2017 Financial Results (PR Newswire)
03-11-2018
Week 11 Breakout Forecast: Short-Term Picks To Give You An Edge (SeekingAlpha)
03-08-2018
Infinity Announces the Date of Its Fourth Quarter and Full Year 2017 Financial Results Conference Call and Webcast (PR Newswire)
03-08-2018
Infinity Pharmaceuticals Announces Additions to Board of Directors and Clinical Leadership Team and Establishes Scientific Advisory Board (PR Newswire)


Smart Money Sentiment

Institutional Ownership (Top 15 Funds) 48.9%
Insider Percent5.5%

Earnings Stats

PE Ratio -2.65
Dividend Yield 0%
Peer EarningsEarnings Calendar

Technicals

200 Day Moving Average $1.83
50 Day Moving Average $2.15
52 Week High $3.75
52 Week Low $0.93



Data provided for free by IEX. Questions? Read the FAQ